Our mission is to deliver the greatest possible impact to people through mRNA medicines.
At Moderna, we believe messenger RNA, or mRNA, is the “software of life.”
Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease.
Given its essential role, we believe mRNA could be used to create a new category of medicines with significant potential to improve the lives of patients.
We are pioneering a new class of medicines made of messenger RNA, or mRNA. The potential implications of using mRNA as a drug are significant and far-reaching and could meaningfully improve how medicines are discovered, developed and manufactured.
To learn more, visit www.modernatx.com.
This Moderna page is not the appropriate place to report adverse events (side-effects) for any products. If you are or someone you know is experiencing a side effect, please reach out to your healthcare professional. Moderna is continuously monitoring the safety of its products. We encourage you to report any side effects directly to us at 1‐866‐MODERNA (1‐866‐663‐3762).
Biotechnology and mRNA Therapeutics
Pioneering mRNA technology - Moderna France
Entity | Type | Tweets | Articles | |
---|---|---|---|---|
European Pharmaceutical Review Pharmaceutical Manufacturing | Other 15 Dec 2023 | | ||
Génome Québec greentech, agritech, biotech, cleantech, edtech, deeptech, healthtech, Biotechnology Research | Other 11 May 2022 | | ||
International AIDS Society healthtech, Non-profit Organizations | Other 28 Jan 2022 | | ||
Life Sciences BC biotech, deeptech, healthtech, Biotechnology Research | Other 12 Sep 2024 | | ||
AIS Congress biotech, deeptech, Pharmaceutical Manufacturing | Not capitalistic Not partnership Event 26 Jun 2022 | | ||
ActionAid UK edtech, Non-profit Organizations | Other 28 Apr 2022 31 Mar 2022 | | | |
BioM Biotech Cluster Development GmbH Biotechnology Research | Other 12 Sep 2023 | | ||
Africa CDC healthtech, Hospitals and Health Care | Other 3 Feb 2022 | |